dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ribera, Josep-Maria |
dc.contributor.author | Tormo, Mar |
dc.contributor.author | Martínez-Carballeira, Daniel |
dc.contributor.author | González-Campos, José |
dc.contributor.author | Barba Suñol, Pere |
dc.contributor.author | Montesinos, Pau |
dc.contributor.author | Morgades, Mireia |
dc.date.accessioned | 2021-10-22T06:31:07Z |
dc.date.available | 2021-10-22T06:31:07Z |
dc.date.issued | 2020-04 |
dc.identifier.citation | Ribera J, Morgades M, Montesinos P, Tormo M, Martínez‐Carballeira D, González‐Campos J, et al. A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: results of the ALLRE08 PETHEMA trial. Cancer Med. 2020 Apr;9(7):2317–29. |
dc.identifier.issn | 2045-7634 |
dc.identifier.uri | https://hdl.handle.net/11351/6440 |
dc.description | Leucèmia limfoblàstica aguda; Adolescents i adults joves; Tractament pediàtric |
dc.description.sponsorship | Supported in part by grants PI14/01971 from Fondo de Investigaciones Sanitarias, Instituto Carlos III, SGR288 (GRC) Generalitat de Catalunya, Fundació La Caixa and CIBERONC (JMHR and AO). |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Cancer Medicine;9(7) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Leucèmia limfoblàstica - Quimioteràpia |
dc.subject | Adolescents |
dc.subject.mesh | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Adolescent |
dc.title | A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: results of the ALLRE08 PETHEMA trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/cam4.2814 |
dc.subject.decs | leucemia-linfoma linfoblástico de células precursoras |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | adolescente |
dc.relation.publishversion | https://doi.org/10.1002/cam4.2814 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ribera JM, Morgades M] Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Montesinos P] Departments of Clinical Hematology, Hospital Universitari i Politècnic La Fe, CIBERONC, Instituto Carlos III, Valencia, Spain, Madrid, Spain. [Tormo M] Departments of Clinical Hematology, Hospital Clínico Valencia, Valencia, Spain. [Martínez-Carballeira D] Hospital Central de Asturias, Oviedo, Spain. [González-Campos J] Departments of Clinical Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. [Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 32022463 |
dc.identifier.wos | 000511017000001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI14%2F01971 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |